A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
The government-funded study was small and experts say it's not yet clear how safe these drugs are for people who don't need ...
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
13h
Hosted on MSNWill Eli Lilly Stock Keep Climbing? Q2 Trial Results Are CrucialEli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results